Published in Ann Surg Oncol on April 16, 1999
Clinical evidence of breast cancer micrometastasis in the era of sentinel node biopsy. Int J Clin Oncol (2008) 0.89
Sentinel lymph node biopsy progress in surgical treatment of cancer. Langenbecks Arch Surg (2004) 0.87
Spectral detection of micro-metastases in lymph node histo-pathology. J Biophotonics (2009) 0.81
Prediction of metastasis to non-sentinel nodes by sentinel node status and primary tumor characteristics in primary breast cancer in Taiwan. World J Surg (2005) 0.79
Sentinel node biopsy in early breast cancer in Taiwan. World J Surg (2002) 0.77
Microstaging of sentinel lymph nodes. Ann Surg Oncol (1999) 0.76
Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system. J Clin Oncol (2001) 10.20
Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma. J Clin Oncol (2001) 9.68
Lymphatic mapping and sentinel node biopsy in the patient with breast cancer. JAMA (1996) 4.13
Constitutive activation of Stat3 by the Src and JAK tyrosine kinases participates in growth regulation of human breast carcinoma cells. Oncogene (2001) 3.96
Multi-institutional melanoma lymphatic mapping experience: the prognostic value of sentinel lymph node status in 612 stage I or II melanoma patients. J Clin Oncol (1999) 3.74
Human beta-nerve growth factor gene sequence highly homologous to that of mouse. Nature (1983) 3.17
Guidelines for sentinel node biopsy and lymphatic mapping of patients with breast cancer. Ann Surg (1998) 2.90
Implementation of new surgical technology: outcome measures for lymphatic mapping of breast carcinoma. Ann Surg Oncol (1999) 2.36
The orderly progression of melanoma nodal metastases. Ann Surg (1994) 2.16
Effective treatment of cutaneous and subcutaneous malignant tumours by electrochemotherapy. Br J Cancer (1998) 2.11
Lymphatic mapping and sentinel lymph node biopsy in patients with melanoma of the lower extremity. Plast Reconstr Surg (1999) 2.02
Factors affecting morbidity, mortality, and survival in patients undergoing Ivor Lewis esophagogastrectomy. Ann Surg (2000) 1.98
Bacteriologic and pharmacodynamic aspects of nalidixic acid. J Urol (1970) 1.95
In support of sentinel node biopsy as a standard of care for patients with malignant melanoma. Dermatol Surg (2000) 1.95
Importance of lymphatic mapping in ductal carcinoma in situ (DCIS): why map DCIS? Am Surg (2001) 1.87
Abdominal obesity and breast cancer risk. Ann Intern Med (1990) 1.83
Pathologic examination of the sentinel lymph node in malignant melanoma. Am J Surg Pathol (1999) 1.68
Radioguided surgery for the ultrastaging of the patient with melanoma. Cancer J Sci Am (1998) 1.67
Sentinel lymph node biopsy for melanoma: how many radioactive nodes should be removed? Ann Surg Oncol (2001) 1.66
Evaluation of an intensive strategy for follow-up and surveillance of primary breast cancer. Ann Surg Oncol (1998) 1.64
Molecular staging of malignant melanoma: correlation with clinical outcome. JAMA (1998) 1.62
Detection of submicroscopic lymph node metastases in patients with melanoma. Arch Surg (1991) 1.61
Radiologic, endoscopic, and surgical considerations of melanoma metastatic to the gastrointestinal tract. Surgery (1984) 1.59
Single-dose oral ciprofloxacin versus placebo for prophylaxis during transrectal prostate biopsy. Urology (1998) 1.57
Sentinel-lymph-node biopsy for breast cancer--not yet the standard of care. N Engl J Med (1998) 1.54
Treatment of cutaneous and subcutaneous tumors with electrochemotherapy using intralesional bleomycin. Cancer (1998) 1.54
The effects of postinjection massage on the sensitivity of lymphatic mapping in breast cancer. J Am Coll Surg (2001) 1.53
Malignant melanoma and pregnancy. Cancer (1985) 1.47
Influence of physician communication on newly diagnosed breast patients' psychologic adjustment and decision-making. Cancer (1994) 1.46
Obesity and body fat distribution and breast cancer prognosis. Cancer (1991) 1.46
Age as a prognostic factor in the malignant melanoma population. Ann Surg Oncol (1994) 1.43
Pregnancy-associated hospitalizations in the United States in 1991 and 1992: a comprehensive view of maternal morbidity. Am J Obstet Gynecol (1998) 1.43
Analysis of residual cancer after diagnostic breast biopsy: an argument for fine-needle aspiration cytology. Ann Surg Oncol (1995) 1.42
Cutaneous lymphatic drainage in patients with grossly involved nodal basins. Ann Surg Oncol (1999) 1.42
Monoamine oxidase and catechol-O-methyltransferase activity in hamster and rat insulinomas. Diabetologia (1979) 1.41
Phase I/II trial for the treatment of cutaneous and subcutaneous tumors using electrochemotherapy. Cancer (1996) 1.41
Panic disorder and depression in female alcoholics. J Clin Psychiatry (1988) 1.40
Screening mammography in the Tampa Bay area: current status and implications for the next decade. J Fla Med Assoc (1989) 1.39
Lymphatic mapping and sentinel node biopsy in the management of high-risk melanoma. J Am Acad Dermatol (1998) 1.38
Sentinel node biopsy in ductal carcinoma in situ patients. Ann Surg Oncol (2000) 1.38
Randomized prospective evaluation of a novel technique for biopsy or lumpectomy of nonpalpable breast lesions: radioactive seed versus wire localization. Ann Surg Oncol (2001) 1.38
Chlorhexidine. An adjunct to periodontal therapy. J Periodontol (1986) 1.37
Tumor biology of infiltrating lobular carcinoma. Implications for management. Ann Surg (1995) 1.35
Clinical patterns of metastasis. Cancer Metastasis Rev (2006) 1.32
Lethal "thin" malignant melanoma. Identifying patients at risk. Ann Surg (1988) 1.30
The urethra and its relationship to urinary tract infection. II. The urethral flora of the female with recurrent urinary infection. J Urol (1968) 1.29
Pharmaceutical care research and education project: patient outcomes. J Am Pharm Assoc (Wash) (2001) 1.28
Redefinition of cutaneous lymphatic drainage with the use of lymphoscintigraphy for malignant melanoma. Am J Surg (1991) 1.28
Learning curves for breast cancer sentinel lymph node mapping based on surgical volume analysis. J Am Coll Surg (2001) 1.28
Pharmaceutical care research and education project: pharmacists' interventions. J Am Pharm Assoc (Wash) (2001) 1.27
Touch preparation cytology of breast lumpectomy margins with histologic correlation. Arch Surg (1991) 1.27
Gentamicin. Med Clin North Am (1970) 1.27
Efficacy of elective lymph node dissection in patients with intermediate thickness primary melanoma. Ann Surg (1983) 1.26
Reduction in drug-induced DNA double-strand breaks associated with beta1 integrin-mediated adhesion correlates with drug resistance in U937 cells. Blood (2001) 1.26
Factors that predict the presence of sentinel lymph node metastasis in patients with melanoma. Surgery (2001) 1.26
The urethra and its relationship to urinary tract infection: the flora of the normal female urethra. South Med J (1966) 1.22
NCCN Practice Guidelines for Breast Cancer. Oncology (Williston Park) (2000) 1.22
Prevalence and clinical association of clonal T-cell expansions in Myelodysplastic Syndrome. Leukemia (2007) 1.16
Detection of submicroscopic lymph node metastases with polymerase chain reaction in patients with malignant melanoma. Ann Surg (1994) 1.16
The role of sentinel lymph node biopsy in breast cancer. J Am Coll Surg (1999) 1.14
Perineal, vaginal and urethral bacteriology of young women. I. Incidence of gram-negative colonization. J Urol (1974) 1.13
Selective lymphadenectomy in patients with Merkel cell (cutaneous neuroendocrine) carcinoma. Ann Surg Oncol (1997) 1.12
Risk factors for bladder tumors in spinal cord injury patients. J Urol (1996) 1.11
Sentinel lymph node biopsy for melanoma: controversy despite widespread agreement. J Clin Oncol (2001) 1.10
Intraoperative radio-lympho-scintigraphy improves sentinel lymph node identification for patients with melanoma. Ann Surg (1996) 1.09
Tools used to help community pharmacists implement comprehensive pharmaceutical care. J Am Pharm Assoc (Wash) (2000) 1.08
Mitomycin C inactivation of leukocytes in the mixed leukocyte culture. Transplantation (1973) 1.07
Fournier's gangrene: therapeutic impact of hyperbaric oxygen. Plast Reconstr Surg (1998) 1.07
Metastatic malignant melanoma with an unknown primary. Surg Gynecol Obstet (1983) 1.06
Altered naive and memory CD4+ T-cell homeostasis and immunosenescence characterize younger patients with myelodysplastic syndrome. Leukemia (2009) 1.06
Cost analysis of sentinel lymph node biopsy as an alternative to elective lymph node dissection in patients with malignant melanoma. Surg Oncol Clin N Am (1999) 1.06